Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2266)
All Articles published online
|
Publishing Process of This Article
|
Jan 28, 2025 (publication date) through Aug 13, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Pirola L. Elafibranor, a dual PPARα and PPARδ agonist, reduces alcohol-associated liver disease: Lessons from a mouse model. World J Gastroenterol 2025; 31(4): 99312 [PMID: 39877705 DOI: 10.3748/wjg.v31.i4.99312] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v31/i4/99312.htm |
| Number | Citing Articles |
| 1 |
Alka Singh, Ansab Akthar, Prashant Shukla. Exploring hepatic stellate cell-driven fibrosis: therapeutic advances and future perspectives. ADMET and DMPK 2025; : 2874 doi: 10.5599/admet.2874
|
| 2 |
Min Guo, Jian-nan Cao, Xiao-dong Li, Ling Jin. Key Transcription Factors: Avenue for Treating Alcoholic Liver Disease. Current Medical Science 2025; doi: 10.1007/s11596-025-00079-3
|
| 3 |
Yue Feng, PanShiLi Han, Tao Liu, YanHang Gao. MetALD: new insights and unraveling therapeutic potential. Metabolism and Target Organ Damage 2025; 5(3) doi: 10.20517/mtod.2025.65
|